Cargando…
Lung Molecular Cytopathology: EGFR and Beyond
Lung cancer (LC) is the leading cause of cancer-related mortality. Unfortunately, most patients of LC present at the advanced stage of the disease with a poor prognosis and 1-year survival of less than 20%. At the advanced stage of the disease, surgical resection cannot be possible, hence small biop...
Autor principal: | Jain, Deepali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425779/ https://www.ncbi.nlm.nih.gov/pubmed/30992650 http://dx.doi.org/10.4103/JOC.JOC_135_18 |
Ejemplares similares
-
EBUS-TBNA for Diagnosis of Extrapulmonary Lesions
por: Jain, Deepali
Publicado: (2019) -
Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
por: Jain, Deepali
Publicado: (2018) -
The practice of cytopathology during the era of COVID-19: challenges and changes
por: Baskota, Swikrity Upadhyay, et al.
Publicado: (2021) -
Sex and Biology: Broader Impacts Beyond the Binary
por: Sharpe, Sam L, et al.
Publicado: (2023) -
Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)